
Development of a secretable frataxin for Friedrich’s ataxia with Dr. Dan DuBreuil
In this episode, recorded on-site at the ASGCT 2026 Annual Meeting, Molecular Therapy Advances Associate Editor-in-Chief Dr. Dan Stone speaks with Dr. Dan DuBreuil of Sanofi. They break down the science behind a recent paper detailing the development of a secretable frataxin, highlighting its potential to improve treatment efficacy for Friedreich’s ataxia. Music: 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.auShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.
Publisher
ASGCT Podcast Network
Link
omny.fm/shows/asgct-podcast-network/development-of-a-secretable-frataxin-for-friedrich-s-ataxia-with-dr-dan-dubreuil
Published
June 4, 2026
Duration
20 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
American Society of Gene & Cell Therapy
ASGCT Podcast Network
@asgctpodcastnetwork
#secretablefrataxin #friedrichsataxia #dandubreuil #lifesciences #chemistry #medicine
